Cost Sharing Program In Part D From Coalition Of Cancer Drug Manufacturers Rebuffed By OIG

 
• By Cathy Kelly
  
Program Would Cover 90% Of Oncology Drug Use In Part D • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Compliance

More from Pink Sheet